Ā | Albuminuria without renal impairment | Nonalbuminuric renal impairment |
---|---|---|
n,(%) | 200 (13.5) | 217 (14.7) |
Age, mean (SD) | 67.49 (11.89) | 72.35 (9.94)a |
Gender, men (%) | 137 (68.5) | 75 (34.6)a |
Type 2 DM duration, years (SD) | 7.13 (4.89) | 8.41 (6.43)a |
Obesity, n (%) | 75 (44.4) | 79 (39.3)a |
BP, mmHg (SD) | 139.79/77.79 (15.22/9.35) | 138.12/75.38 (14.22/8.72)b |
HbA1c, mean (SD) | 7.27 (1.61) | 6.68 (1.42)a |
Total cholesterol, mean (SD) | 187.74 (37.38) | 193.17 (36.66) |
Non-HDL cholesterol, mg/dl, mean (SD) | 141.75 (34.89) | 141.81 (35.75) |
Creatinine, mg/dl (SD) | 0.87 (0.17) | 2.38 (1.60)a |
GFR, mil/min/1.73 m 2 (SD) | 92.49 (58.24) | 36.55 (19.28)a |
Tobacco, n (%) | 34 (18.1) | 15 (7.0)b |
Macrovascular disease, n (%) | 46 (23.8) | 33 (15.4)a |
CHD,n (%) | 37 (19.2) | 21 (9.8)a |
Stroke, n (%) | 10 (5.2) | 15 (6.9) |
Diabetic retinopathy, n (%) | 23 (20.2) | 25 (18.9) |
Insulin treatment, n (%) | 43 (22.0) | 43 (19.9) |
Calibrated Framingham CV risk eq. & 10%, n (%) | 14 (10.4) | 7 (6.3) |